Amino acid identified as key to survival in severe illness, study shows

Scientists at the Salk Institute have uncovered a surprising nutritional link that may determine whether an infection becomes life-threatening or resolves on its own. Their work points to methionine, a common dietary amino acid, as a factor that can reshape how the body handles inflammation—largely by helping the kidneys clear dangerous immune signals from the bloodstream.

The discovery emerged from experiments that tracked how small metabolic differences change the course of disease. By tweaking dietary methionine in mice, researchers observed substantial shifts in survival, organ function, and inflammatory signaling—findings that could reframe how clinicians think about nutrition during infection and critical illness.

How a simple amino acid became the focus of infection research

Researchers studying “disease trajectories”—the path from infection to either recovery or death—wanted to know why genetically similar animals sometimes follow very different outcomes. The team, led by Janelle Ayres, PhD, explored whether metabolic and dietary factors might tilt the balance.

They found the answer unexpectedly pointed to methionine, an essential amino acid most commonly obtained through animal proteins. Instead of acting directly on the pathogens, methionine appeared to influence the body’s inflammatory response by supporting organ systems that remove inflammatory molecules.

The role of inflammation and why controlling it matters

Inflammation is the immune system’s frontline reaction to injury and infection. Immune cells release signaling proteins called cytokines to amplify and coordinate the response, but when cytokine levels get out of hand they can damage healthy tissue and cause organ failure.

• Pro-inflammatory cytokines can be as harmful as the infection itself. Excessive levels are often what drive severity and mortality in systemic infections.
• The immune system must strike a balance: mount a sufficient attack on pathogens while avoiding collateral harm to the host.
• The Salk team focused on how the body regulates cytokine clearance—an underappreciated but potentially crucial control point.

Kidneys emerge as unexpected partners in controlling inflammation

Instead of only looking at immune cell behavior, scientists investigated the body’s ability to clear cytokines from circulation. Their experiments showed that kidney function plays an integral role in removing excess inflammatory signals.

Methionine supplementation improved renal filtration and blood flow in infected animals, enabling the kidneys to excrete more pro-inflammatory cytokines into the urine. Crucially, this process reduced harmful systemic inflammation without blunting the immune system’s capacity to kill pathogens.

Mechanism in brief

1. Infection triggered systemic inflammation and reduced food intake, causing measurable drops in circulating amino acids.
2. Methionine levels fell in infected mice, prompting researchers to test whether replacing it changed outcomes.
3. Dietary methionine restored kidney filtration efficiency and enhanced the clearance of cytokines.
4. The result was lower systemic cytokine levels, less collateral tissue damage, and improved survival.

Mouse studies: diet changed the course of disease

Using a mouse model infected with Yersinia pseudotuberculosis, the investigators documented that animals given methionine-supplemented chow were significantly more likely to survive severe infection than unsupplemented controls. The supplemented mice avoided common downstream complications such as wasting and blood-brain barrier breakdown.

The protective effect was not limited to this single pathogen. Additional experiments using models of sepsis and kidney injury produced similar benefits, suggesting the methionine-kidney interaction may apply broadly across inflammatory conditions.

Key experimental observations

• Methionine levels dropped during infection; supplementation reversed this deficit.
• Supplemented animals had improved kidney perfusion and filtration metrics.
• Cytokine concentrations in the bloodstream fell, while bacterial clearance remained effective.
• Outcomes improved across diverse models, including sepsis and renal injury.

Why this matters for patients, especially those with kidney problems

These findings point toward a nutritional avenue for modulating inflammation that is both simple and potentially scalable. For patients with compromised renal function, or those on dialysis, strategies that support cytokine clearance could be particularly relevant.

• Potential clinical scenarios: infection management in patients with chronic kidney disease, adjunctive nutrition during sepsis, or perioperative care for vulnerable individuals.
• Methionine-based interventions might be most useful when tailored to a patient’s metabolic and renal status rather than applied universally.
• Because the effect preserves pathogen killing while lowering harmful inflammation, it represents a different therapeutic logic than broad immune suppression.

Open questions and next steps for research and care

While the animal data are compelling, translating dietary methionine into human treatments requires further work. Important questions remain about dosing, timing, safety, and long-term effects, especially since methionine metabolism intersects with other pathways involved in cardiovascular and liver health.

• What dose and duration of methionine supplementation are safe and effective in people?
• How do age, existing kidney dysfunction, and concurrent medications alter the response?
• Can biomarkers identify patients most likely to benefit from this approach?
• What are the implications for dietary guidance in hospitals and intensive care units?

The Salk Institute team frames this work as part of a broader shift toward using nutritional elements as targeted, mechanism-informed medical tools. Their studies add to growing evidence that small metabolic differences can produce large changes in disease outcomes—and that supporting organ systems responsible for clearing inflammation may be as important as fighting the pathogens themselves.

You might also like:

• Root canal treatment reduces heart disease and diabetes risk, study finds
• Art gallery visits linked to lower heart disease risk, study finds
• Tuberculosis DNA vaccine nasal delivery shows therapeutic promise in Johns Hopkins study
• Desert mouse defies aging: study could reshape human longevity research
• DMT, the spirit molecule, protects brain from stroke in mice, study finds

Michael Thompson

Michael Thompson is an experienced journalist covering U.S. and global news. With ten years on the front lines, he breaks down political and economic stories that matter. His precise writing and keen attention to detail help you grasp the real‑world impact of every event.